Dow Jones

40 211,72

0,53%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
Teva Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:TEVA

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
02/11/2021	03h00	Business Wire	California Judge Rules That Teva Did Not Cause a Public Nuisance or Make False or Misleading Statements About Opioids	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
30/10/2021	22h00	Business Wire	New Phase 3 Data Presented at Psych Congress 2021 Showed TV-46000/mdc-IRM Significantly Prolonged Time to Impending Relapse Compared to Placebo in Patients with Schizophrenia	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/10/2021	14h52	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/10/2021	13h15	Business Wire	Teva Announces $3,500,000,000 Debt Tender Offers for Notes Due 2022-2024	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/10/2021	13h15	Business Wire	Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/10/2021	13h14	Edgar (US Regulatory)	Quarterly Report (10-q)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/10/2021	13h01	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/10/2021	13h00	Business Wire	Teva Reports Third Quarter 2021 Financial Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
26/10/2021	22h45	Business Wire	Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
21/10/2021	14h00	Business Wire	Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
13/10/2021	19h53	Business Wire	Nouvelles données relatives à l'innocuité du traitement par COPAXONE® (acétate de glatiramère) chez des mères allaitantes atteintes de sclérose en plaques cyclique	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
13/10/2021	17h33	Business Wire	Neue Sicherheitsdaten zur Behandlung mit COPAXONE® (Glatirameracetat) von stillenden Müttern mit schubförmiger multipler Sklerose	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
13/10/2021	08h00	Business Wire	New Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live with Relapsing Multiple Sclerosis	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
04/10/2021	19h59	Business Wire	Les distances parcourues par les médicaments deviennent une source d'inquiétude pour les patients européens	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
04/10/2021	16h54	Business Wire	„Medicine Miles“ werden zu einem Problem für europäische Patienten	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
04/10/2021	13h21	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
04/10/2021	08h00	Business Wire	‘Medicine Miles’ Becoming a Concern for European Patients	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/10/2021	16h20	Business Wire	Teva to Host Conference Call to Discuss Third Quarter 2021 Financial Results at 8 a.m. ET on October 27, 2021	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
30/09/2021	14h00	Business Wire	Teva to Present 8 Abstracts on AJOVY® (fremanezumab-vfrm) Injection and Hold Symposium on Healthcare Disparities at WCN	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
30/09/2021	13h30	Business Wire	Teva Enlists Sarah Michelle Gellar to Launch “Inhaler Tales” Campaign to Raise Awareness About Inhaler Use in Asthma and COPD	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
28/09/2021	19h39	Dow Jones News	Teva Pharma Shares Up 6% After Louisiana Opioid Settlement	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
28/09/2021	18h40	Business Wire	Teva Reaches Agreement with Louisiana to Settle the State’s Opioid-Related Claims	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
08/09/2021	14h00	Business Wire	Late-Breaking Data at the International Headache Society & European Headache Federation Joint Congress 2021 Showed AJOVY® (fremanezumab-vfrm) Injection Reduced More Monthly Migraine Days in a Network Meta-Analysis Study with Atogepant and Rimegepant	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
31/08/2021	23h11	Dow Jones News	Teva, MedinCell Say FDA Accepts NDA for Schizophrenia Treatment	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
31/08/2021	22h15	Business Wire	Teva et MedinCell annoncent l’acceptation par la FDA du dossier de demande d’approbation du traitement TV46000/mdc-IRM pour les patients atteints de schizophrénie	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
31/08/2021	22h15	Business Wire	Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
30/08/2021	14h00	Business Wire	Showcasing Teva’s Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be presented, Including One Late-Breaker, on AJOVY® (fremanezumab-vfrm) Injection at the International Headache Society and European Headache...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
20/08/2021	14h00	Business Wire	Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (deutetrabenazine) Tablets in Adult Patients with Tardive Dyskinesia	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
12/08/2021	22h04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
28/07/2021	13h30	Business Wire	Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis	NYSE:TEVA	Teva Pharmaceutical Industries Ltd